Thermo Fisher Scientific Inc. (TMO)
Sector: Technology
Industry: Measuring & Controlling Devices, NEC
Country: United States
Exchange: NYSE
Market cap: $243.41B
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
Latest financial period: June 27, 2026
Filed with the SEC: July 31, 2026
Estimated earnings date: October 28, 2026
Profit #808 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROIC | 8.8% | 8.7% | 9.0% | 8.5% |
Growth #794 of 1484 companies
Payout #71 of 1484 companies
Safety #232 of 1484 companies
Price #1003 of 1484 companies
